A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
etanercept-ykro, Erelzi, Eticovo, Enbrel, etanercept-szzs,
Synonyms :
Class :
Antirheumatics snd TNF alfa inhibitors
Dosage Forms & Strengths: Â
Solution Â
25 mg/0.5 mL (0.5 mL) Â
Solution Auto-injector Â
50 mg/mL (Enbrel SureClick) Â
Solution Cartridge Â
50 mg/mL (Enbrel Mini) Â
Solution Prefilled Syringe Â
25 mg/0.5 mL (Enbrel) Â
50 mg/mL (Enbrel) Â
Solution Reconstituted Â
25 mg (Enbrel) Â
Dosage Forms & Strengths: Â
Solution Â
25 mg/0.5 mL (0.5 mL) Â
Solution Auto-injector Â
50 mg/mL (Enbrel SureClick) Â
Solution Cartridge Â
50 mg/mL (Enbrel Mini) Â
Solution Prefilled Syringe Â
25 mg/0.5 mL (Enbrel) Â
50 mg/mL (Enbrel) Â
Solution Reconstituted Â
25 mg (Enbrel) Â
coccidioides immitis skin test
it may reduce the diagnostic effect of coccidioides immitis skin test 
it may reduce the therapeutic effect of covid-19 vaccine (subunit) 
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
it may increase the immunosuppressive effect of abatacept 
it may increase the immunosuppressive effect of immunosuppressants  
it may increase the risk of adverse effects of anakinra 
it may increase the immunosuppressive effect of anifrolumab 
it may increase the immunosuppressive effect of baricitinib 
it may increase the risk of adverse effects of bcg products 
it may increase the immunosuppressive effect of biologic disease-modifying antirheumatic agents 
biologic disease modifying antirheumatic drugs (dmards)
it may increase the immunosuppressive effect of other biologic disease-modifying antirheumatic drugs 
It may enhance the immunosuppressive effects when combined with idecabtagene vicleucel
when etanercept is used in combination with diphtheria & tetanus toxoids, this leads to a reduction in the effects of diphtheria & tetanus toxoids through pharmacodynamic antagonism
when both drugs are combined, there may be an increased metabolism of etoposide   
when both drugs are combined, the metabolism of paclitaxel increases when compared with etanercept  
when both the drugs are combined, the metabolism of carmustine increases    
When both drugs are combined, there may be an increased risk or severity of adverse effects  
when both drugs are combined, there may be an increased risk or severity of adverse effects  
when both drugs are combined, there may be an increased risk or severity of adverse effects   
when both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections   
when both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections  
when both drugs are combined, there may be an increased risk or severity of adverse effects   
when both drugs are combined, there may be an increased risk or severity of adverse effects  
interaction raises immunosuppressive effects and risk of infection
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of abatacept
may increase the immunosuppressive effect of abatacept
may increase the immunosuppressive effect of certolizumab pegol
may have an increased immunosuppressive effect when combined with anifrolumab
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
the toxicity of either of the drugs is increased by immunosuppressive activity
respiratory syncytial virus vaccine, adjuvanted
may diminish the pharmacodynamic antagonistic effect of each other when combined
respiratory syncytial virus (RSV) vaccine
may diminish the pharmacodynamic antagonistic effect of each other when combined
may diminish the pharmacodynamic antagonistic effect of each other when combined
pneumococcal vaccine polyvalentÂ
the activity of pneumococcal vaccine polyvalent is reduced due to pharmacodynamic antagonism
it may reduce the therapeutic effect of brincidofovir 
immunosuppressants (therapeutic immunosuppressant agents) may enhance the immunosuppressive effect of cladribine. risk x: avoid combination 
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Antipsoriatics drugs
When acetohexamide is used together with etanercept, this lead to rise in acetohexamide’s metabolism
When etanercept is used in combination with rabies vaccine, this leads to a reduction in the rabies vaccine effects through the process of pharmacodynamic antagonism
both the drugs increase the effect of immunosuppression risk of infection increases on administering both the drugs simultaneously
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
When etanercept is used together with lomitapide, this leads to an enhancement in lomitapide’s metabolism
Adverse drug reactions:  Â
Frequency Defined Â
>10% Â
Diarrhea (16%) Â
Rash (13%) Â
Infection (81%) Â
Upper respiratory infections (65%) Â
Injection site reactions (43%) Â
Non-upper respiratory infections (54%) Â
1-10% Â
Urticaria (2%) Â
Hypersensitivity (1%) Â
Pruritus (5%) Â
Pyrexia (2%) Â
Post marketing Reports Â
Pancytopenia Â
Leukopenia Â
Neutropenia Â
Thrombocytopenia Â
Lymphadenopathy Â
aplastic anemia Â
Congestive heart failure Â
Inflammatory bowel disease (IBD Â
Angioedema Â
Pregnancy warnings:    
Pregnancy Category: N/AÂ Â
Lactation: knownÂ
Pregnancy Categories:      Â
Patient Information Leaflet   Â
Generic Name: etanercept (Rx)Â
Why do we use etanercept (Rx)?Â
etanercept (Rx) belongs to the class of Antirheumatics, TNF alfa inhibitors which helps to treat plaque psoriasis, Alzheimer’s disease, and joint damage in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis.